A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial

Abstract

In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the treatment of cardiovascular diseases. Analyzed in detail the selection of b-AB inside the class from the standpoint of pharmacokinetics, selectivity, study in clinical studies. Data about efficiency and safety of application of metoprolol succinate for the treatment of arterial hypertension, coronary heart disease, chronic heart failure.

Keywords

• arterial hypertension
• ischemic heart disease
• chronic heart failure
• b-blockers
• metoprolol succinate